Carriers for metal complexes on tumour cells: The effect of cyclodextrins vs CNTs on the model guest phenanthroline-5,6-dione trithiacyclononane ruthenium(II) chloride

BioMetals

Volumn 27, Issue 3, 2014, Pages 507-525

  Braga, Susana S ^a   Marques, Joana ^a   Heister, Elena ^b   Diogo, Cátia V ^c   Oliveira, Paulo J ^c   Paz, Filipe A Almeida ^d   Santos, Teresa M ^d   Marques, Maria Paula M ^e  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

1,10 Phenanthroline 5,6 dione; Carbon nanotubes; Cyclodextrins; Cytotoxicity; Ruthenium complexes

Indexed keywords

ALCOHOL; CARBON NANOTUBE; CYCLODEXTRIN; PHENANTHROLINE 5,6 DIONE TRITHIACYCLONONANE RUTHENIUM(II)CHLORIDE; RUTHENIUM COMPLEX; SALICYLIC ACID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CALF THYMUS DNA; COORDINATION COMPOUND; DNA; DRUG CARRIER; NANOCAPSULE; PHENANTHROLINE-5,6-DIONE TRITHIACYCLONONANE RUTHENIUM(II);

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CULTURE; CRYSTAL; CRYSTALLIZATION; CYTOTOXICITY; DENATURATION; DRUG DELIVERY SYSTEM; IN VITRO STUDY; INFRARED SPECTROSCOPY; MELANOMA CELL LINE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SUSTAINED DRUG RELEASE; THERMOGRAVIMETRY; TUMOR CELL; X RAY DIFFRACTION; ANIMAL; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; CONFORMATION; DRUG EFFECTS; DRUG SCREENING; HUMAN; IC50; MCF 7 CELL LINE; MELANOMA; MOUSE; MYOBLAST; POWDER DIFFRACTION; RAT; TRANSITION TEMPERATURE; X RAY CRYSTALLOGRAPHY;

RATTUS; RODENTIA;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; COORDINATION COMPLEXES; CRYSTALLOGRAPHY, X-RAY; CYCLODEXTRINS; DNA; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; MCF-7 CELLS; MELANOMA; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MYOBLASTS, CARDIAC; NANOCAPSULES; NANOTUBES, CARBON; POWDER DIFFRACTION; RATS; THERMOGRAVIMETRY; TRANSITION TEMPERATURE;

EID: 84902543205     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9725-8     Document Type: Article

References (67)

1. Alanyali FS, Ergin E, Artagan O, Benkli K (2011) Investigation of genotoxic effects of some ruthenium complexes according to cis-platinum. Int J Pharmacol 7:96-105
2. Ali-Boucetta H, Al-Jamal KT, McCarthy D, Prato M, Bianco A, Kostarelos K (2008) Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics. Chem Commun 4:459-461
3. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818-1822 (Pubitemid 38374867)
4. APEX2 (2006). Data Collection Software Version 21-RC13, Bruker AXS, Delft, The Netherlands
5. Arlt M, Haase D, Hampel S, Oswald S, Bachmatiuk A, Klingeler R, Schulze R, Ritschel M, Leonhardt A, Fuessel S, Büchner B, Kraemer K, Wirth MP (2010) Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death. Nanotechol 21:335101
6. Barroug A, Glimcher MJ (2002) Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro. J Orthop Res 20:274-280 (Pubitemid 34218271)
7. 2) with β-cyclodextrin. J Organomet Chem 632:11-16
8. Braga SS, Gonçalves IS, Herdtweck E, Teixeira-Dias JJC (2003a) Solid state inclusion compound of S-ibuprofen in b-cyclodextrin: structure and characterization. New J Chem 27:597-601 (Pubitemid 36379503)
9. Braga SS, Ribeiro-Claro P, Pillinger M, Gonçalves IS, Pereira F, Fernandes AC, Romão CC, Correia PB, Teixeira-Dias JJC (2003b) Encapsulation of sodium nimesulide and precursors in β-cyclodextrin. Org Biomol Chem 1:873-878
10. Braga SS, Ribeiro-Claro P, Pillinger M, Gonçalves IS, Fernandes AC, Pereira F, Romão CC, Correia PB, Teixeira-Dias JJC (2003c) Interactions of omeprazole and precursors with beta-cyclodextrin host molecules. J Incl Phenom Macrocycl Chem 47:47-52 (Pubitemid 39012098)
11. Braga SS, Paz FAA, Pillinger M, Seixas JD, Romão CC, Gonçalves IS (2006) Structural studies of b-cyclodextrin and permethylated b-cyclodextrin inclusion compounds of cyclopentadienyl metal carbonyl complexes. Eur J Inorg Chem 8:1662-1669
12. Branco AF, Pereira SL, Moreira AC, Holy J, Sardão VA, Oliveira PJ (2011) Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line. Cardiovasc Toxicol 11:191-203
13. Branco AF, Sampaio SF, Moreira AC, Holy J, Wallace KB, Baldeiras I, Oliveira PJ, Sardão VA (2012) Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts. Cardiovasc Toxicol 12:326-340
14. Brandenburg K (1997-2010) DIAMOND, Version 32f Crystal Impact GbR, Bonn, Germany
15. Brechin EK, Calucci L, Englert U, Margheriti L, Pampaloni G, Pinzino C, Prescimone A (2008) 1,10-Phenanthroline-5,6-dione complexes of middle transition elements: mono- and di-nuclear derivatives. Inorg Chim Acta 361:2375-2384
16. Bruno S, Fernandes JA, Marques J, Neto SC, Ribeiro-Claro PJ, Pillinger M, Paz FAA, Marques MPM, Braga SS, Gonçalves IS (2011) Structural studies and cytotoxicity of trimethyl(ferrocenylmethyl)ammonium iodide encapsulated in beta-cyclodextrin. Eur J Inorg Chem 32:4955-4963
17. Caira MR (2001) On the isostructurality of cyclodextrin inclusion complexes and its practical utility. Rev Roum Chim 46:371-386
18. Caira MR, Bourne SA, Mhlongo WT, Dean PM (2004) New crystalline forms of permethylated beta-cyclodextrin. Chem Commun 2004:2216-2217 (Pubitemid 39472546)
19. Chen J-F, Ding H-M, Wang J-X, Shao L (2004) Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25:723-727 (Pubitemid 37357286)
20. Cryopad (2006). Remote monitoring and control, Version 1451, Oxford Cryosystems, Oxford, United Kingdom
21. Davis ME, Brewster ME (2004) Cyclodextrin-based pharmaceuticals: past, present and future. Nature Rev 3:1023-1035 (Pubitemid 39642365)
22. 4 using human epithelial cell lines. Chem Biol Interact 164:115-125
23. Dikmen M, Benkli K, Ozturk Y (2011) Inhibition of C6 glioma cell proliferation by Au(III) and Pt(II) complexes of 1,10-phenanthroline-5,6-dione. Asian J Chem 23:2749-2754
24. Fernandes JA, Lima S, Braga SS, Ribeiro-Claro P, Rodriguez-Borges JE, Teixeira C, Pillinger M, Teixeira-Dias JJC, Gonçalves IS (2005) Inclusion complex formation of diferrocenyldimethylsilane with b-cyclodextrin. J Organomet Chem 690:4801-4808 (Pubitemid 41436541)
25. n+ (dppz = dipyrido[3,2-a:2′,3′-c]phenazine), n = 1-3. J Chem Soc Dalton Trans 19:3664-3673
26. 3 polypyridyl complexes by NMR spectroscopy and single-crystal X-ray diffraction. Polyhedron 16:393-401
27. Goss CA, Abruña HD (1985) Spectral, electrochemical, and electrocatalytic properties of 1,10-phenanthroline-5,6-dione complexes of transition metals. Inorg Chem 24:4263-4267
28. Guven A, Rusakova IA, Lewis MT, Wilson LJ (2012) Cisplatin@ US-tube carbon nanocapsules for enhanced chemotherapeutic delivery. Biomaterials 33:1455-1461
29. 6-Arene)tricarbonylcromium(0) complexes with cyclodextrins. Organometallics 8:730-733
30. Heister E, Lamprecht C, Neves V, Tilmaciu C, Datas L, Flahaut E, Soula B, Hinterdorfer P, Coley HM, Silva SR, McFadden J (2010) Higher dispersion efficacy of functionalized carbon nanotubes in chemical and biological environments. ACS Nano 4:2615-2626
31. Heister E, Neves V, Lamprecht C, Silva SR, Coley HM, McFadden J (2012) Drug loading, dispersion stability, and therapeutic efficacy in targeted drug delivery with carbon nanotubes. Carbon 50:622-632
32. Hilder TA, Hill JM (2008) Carbon nanotubes as drug delivery nanocapsules. Curr Appl Phys 3-4:258-261 (Pubitemid 351172963)
33. Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Controlled Release 155(3):344-357
34. Kottke T, Stalke D (1993) Crystal handling at low-temperatures. J App Cryst 26:615-619
35. 2+ complexes and their antimicrobial activity. Appl Organomet Chem 23:409-420
36. 3+ ion in aqueous solution: supramolecular motifs in the packing 1,10-phenanthroline-5,6-diketone and 1,10-phenanthroline-5,6-diol complexes. Inorg Chim Acta 357:657-664
37. Lin FH, Lee YH, Jian CH, Wong J-M, Shieh M-J, Wang C-Y (2002) A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 23:1981-1987 (Pubitemid 34251072)
38. 3 polypyridylic complexes. J Chem Soc Dalton Trans 23:4422-4431
39. 3)(bpy)Cl]Cl. J Organomet Chem 693:3021-3028
40. Marques J, Braga TM, Paz FAA, Santos TM, Lopes MFS, Braga SS (2009a) Cyclodextrins improve the antimicrobial Activity of the chloride salt of Ruthenium(II) chloro-phenanthroline-trithiacyclononane. Biometals 22:541-556
41. Marques J, Santos TM, Marques MPM, Braga SS (2009b) A glycine ruthenium trithiacyclononane complex and its molecular encapsulation using cyclodextrins. Dalton Trans 44:9812-9819
42. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
43. Nakamoto K (1966) Infrared spectra of inorganic and co-ordination compounds. M. Mir, Moscow
44. Papazisis KT, Geromichalos GD, Dimitriadis KA, Kortsaris AH (1997) Optimization of the sulforhodamine B colorimetric assay. J Immunol Methods 208:151-158 (Pubitemid 28015342)
45. Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boom to drug delivery, therapeutics, diagnostics and imaging. Nanomed Nanotechnol Biol Med 8:147-166
46. Pereira CCL, Nolasco M, Braga SS, Paz FAA, Ribeiro-Claro P, Pillinger M, Gonçalves IS (2007) A combined theoreticalexperimental study of the inclusion of niobocene dichloride in native and permethylated β-cyclodextrins. Organometallics 26:4220-4228 (Pubitemid 47310052)
47. Petrovski Ž, Braga SS, Rodrigues SS, Pereira CCL, Gonçalves IS, Pillinger M, Freire C, Romão CC (2005a) Synthesis of ferrocenyldiimine metal carbonyl complexes and an investigation of the Mo adduct encapsulated in cyclodextrin. New J Chem 29:347-354
48. Petrovski Ž, Braga SS, Santos AM, Rodrigues SS, Gonçalves IS, Pillinger M, Kühn FE, Romão CC (2005b) Synthesis and characterization of the inclusion compound of a ferrocenyldiimine dioxomolybdenum complex with heptakis-2,3,6-tri-O-methyl-beta-cyclodextrin. Inorg Chim Acta 358:981-988
49. Radin S, Ducheyne P, Kamplain T, Tan BH (2001) Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 57:313-320 (Pubitemid 32988512)
50. Ramos AI, Braga TM, Silva P, Fernandes JA, Ribeiro-Claro P, Lopes MFS, Paz FAA, Braga SS (2012) Chloramphenicol ·cyclodextrin inclusion compounds: co-dissolution and mechanochemical preparations and antibacterial action. CrystEngComm 15:2822-2834
51. Roseanu A, Florian PE, Moisei E, Sima LE, Evans RW, Trif M (2010) Liposomalization of lactoferrin enhanced its antitumoral effects on melanoma cells. Biometals 23:485-492
52. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN (2003) Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125:7860-7865 (Pubitemid 36782161)
53. Roy S, Hagen KD, Maheswari PU, Lutz M, Spek AL, Reedijk J, van Wezel GP (2008) Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. ChemMedChem 3:1427-1434
54. SAINT+ (1997-2005). Data Integration Engine v 723a ©:Bruker AXS, Madison, Wisconsin, USA
55. Santos TM, Madureira J, Goodfellow BJ, Drew MGB, de Jesus JP, Félix V (2001) Interaction of Ruthenium(II)-dipyridophenazine complexes with CT-DNA: effects of the polyhioether ancillary ligands. Met Based-Drugs 8:125-135
56. Sardão VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB (2009) Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemother Pharmacol 64:811-827
57. Sheldrick GM (1997a) SHELXS-97, Program for Crystal Structure Solution, University of Göttingen
58. Sheldrick GM (1997b) SHELXL-97, Program for Crystal Structure Refinement, University of Göttingen
59. Sheldrick GM (1998) SADABS v201, Bruker/Siemens Area Detector Absorption Correction Program, Bruker AXS, Madison, WI, USA
60. Sheldrick GM (2008) A short history of SHELX. Acta Cryst A 64:112-122
61. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112 (Pubitemid 20213250)
62. Spek AL (1990) PLATON. Acta Cryst A 46:C34
63. Spek AL (2003) Single-crystal structure validation with the program PLATON. J Appl Crystallogr 36:7-13
64. Szejtli J (1998) Cyclodextrin and general overview of cyclodextrin chemistry. Chem Rev 98:1743-1754
65. van der Sluis P, Spek AL (1990) Acta Cryst A 46:194-201
66. Wagner A, Vorauer-Uhl K (2011) Liposome technology for industrial purposes. J Drug Deliv 2011:591325. doi:10.1155/2011/591325
67. Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand J-P, Gennaro R, Prato M, Bianco A (2005) Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed 44:6358-6362 (Pubitemid 41454662)